檢索結果 - Sasaki, Yasutsuna

Gas-filled Cavities in the Liver 由 Hamada, Kazuyuki, Sasaki, Yasutsuna

獲取全文 獲取全文 獲取全文

Crizotinib-induced pancreatic pseudocyst: a novel adverse event 由 Ishida, Hiroo, Ichikawa, Wataru, Sasaki, Yasutsuna

獲取全文 獲取全文 獲取全文

Does Industry‐Conducted All‐Case Surveillance of Newly Approved Oncology Drugs Contribute to the Revision of Package Inserts in Japan? 由 Suzuki, Akiyuki, Sato, Hitoshi, Sasaki, Yasutsuna

獲取全文 獲取全文 獲取全文

Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy 由 Matsunaga, Mototsugu, Miwa, Keisuke, Noguchi, Tsuyoshi, Sasaki, Yasutsuna

獲取全文 獲取全文 獲取全文

Pharmacokinetic Study of Mitomycin C with Emphasis on the Influence of Aging 由 Miya, Toshimichi, Sasaki, Yasutsuna, Karato, Atsuya, Saijo, Nagahiro

獲取全文 獲取全文 獲取全文

Phase I Study of Paclitaxel by Three‐hour Infusion: Hypotension Just after Infusion Is One of the Major Dose‐limiting Toxicities 由 Tamura, Tomohide, Sasaki, Yasutsuna, Nishiwaki, Yutaka, Saijo, Nagahiro

獲取全文 獲取全文 獲取全文

Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel 由 Minami, Hironobu, Sasaki, Yasutsuna, Watanabe, Torn, Ogawa, Makoto

獲取全文 獲取全文 獲取全文

Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer? 由 Sasaki, Yasutsuna, Hamada, Kazuyuki, Kaneta, Toshikado, Takahashi, Takehiro, Kubota, Yutaro, Ishida, Hiroo, Ichikawa, Wataru

獲取全文 獲取全文 獲取全文

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer 由 Mukai, Hirofumi, Saeki, Toshiaki, Shimada, Ken, Naito, Yoichi, Matsubara, Nobuaki, Nakanishi, Tadashi, Obaishi, Hiroshi, Namiki, Masayuki, Sasaki, Yasutsuna

獲取全文 獲取全文 獲取全文

Inhibition of Colony Formation of Drug‐resistant Human Tumor Cell Lines by Combinations of Interleukin‐2‐activated Killer Cells and Antitumor Drugs 由 Ohtsu, Atsushi, Sasaki, Yasutsuna, Tamura, Tomohide, Fujiwara, Yasuhiro, Ohe, Yuichiro, Minato, Koichi, Nakagawa, Kazuhiko, Bungo, Masami, Saijo, Nagahiro

獲取全文 獲取全文 獲取全文

Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11 由 Sasaki, Yasutsuna, Yoshida, Yasushi, Sudoh, Kenichi, Hakusui, Hideo, Fujii, Hirofumi, Ohtsu, Tomoko, Wakita, Hisashi, Igarashi, Tadahiko, Itoh, Kuniaki

獲取全文 獲取全文 獲取全文

Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan 由 Satoh, Etsuko, Sasaki, Yasutsuna, Ohkuma, Ryotaro, Takahashi, Takehiro, Kubota, Yutaro, Ishida, Hiroo, Hamada, Kazuyuki, Kiuchi, Yuji, Tsunoda, Takuya

獲取全文 獲取全文 獲取全文

Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction 由 Shibata, Takashi, Ebata, Tomoki, Fujita, Ken‐ichi, Shimokata, Tomoya, Maeda, Osamu, Mitsuma, Ayako, Sasaki, Yasutsuna, Nagino, Masato, Ando, Yuichi

獲取全文 獲取全文 獲取全文

Characteristics of miRNA-SNPs in healthy Japanese subjects and non-small cell lung cancer, colorectal cancer, and soft tissue sarcoma patients 由 Katayama, Koki, Nakashima, Shimon, Ishida, Hiroo, Kubota, Yutaro, Nakano, Masataka, Fukami, Tatsuki, Sasaki, Yasutsuna, Fujita, Ken-ichi, Nakajima, Miki

獲取全文 獲取全文 獲取全文

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics 由 Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna

獲取全文 獲取全文 獲取全文

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics 由 Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna

獲取全文 獲取全文

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer 由 Sasaki, Yasutsuna, Nishina, Tomohiro, Yasui, Hirofumi, Goto, Masahiro, Muro, Kei, Tsuji, Akihito, Koizumi, Wasaburo, Toh, Yasushi, Hara, Takuo, Miyata, Yoshinori

獲取全文 獲取全文 獲取全文

A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S−1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG‐M0... 由 Ishiguro, Hiroshi, Saji, Shigehira, Nomura, Shogo, Tanaka, Sunao, Ueno, Takayuki, Onoue, Masahide, Iwata, Hiroji, Yamanaka, Takeharu, Sasaki, Yasutsuna, Toi, Masakazu

獲取全文 獲取全文 獲取全文

The Mechanism of the Difference in Cellular Uptake of Platinum Derivatives in Non‐small Cell Lung Cancer Cell Line (PC‐14) and Its Cisplatin‐resistant Subline (PC‐14/CDDP) 由 Ohmori, Tohru, Morikage, Toshihiko, Sugimoto, Yoshikazu, Fujiwara, Yasuhiro, Kasahara, Kazuo, Nishio, Kazuto, Ohta, Sei, Sasaki, Yasutsuna, Takahashi, Terumi, Saijo, Nagahiro

獲取全文 獲取全文 獲取全文

A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38 由 Sasaki, Yasutsuna, Hakusui, Hideo, Mizuno, Shoichi, Morita, Masashige, Miya, Toshimichi, Eguchi, Kenji, Shinkai, Tetsu, Tamura, Tomohide, Ohe, Yuichiro, Saijo, Nagahiro

獲取全文 獲取全文 獲取全文